top of page

Status of COVID19 Vaccines !!

Writer's picture: MedCuoreMedCuore

Updated: May 13, 2020



There are currently four vaccine leading a race for COVID 19. Nations around the world are under strict lock down in order to avoid further pressure. Meanwhile researchers and scientists are working to develop the vaccines for COVID 19.


1. Oxford University


Oxford University has developed a vaccine candidate ‘ChAdOx1 nCoV-19’ in under three months. The vaccine candidate uses a weakened strain of common cold virus (adenovirus) and is combined with the genetic material of the SARS-CoV-2 (the coronavirus causing COVID-19). This will enable the body to identify the spike protein of the novel coronavirus. The vaccine candidate is now in a clinical trial phase-1 and healthy volunteers have already been injected to check its safety and efficiency


2. ​Massachusetts-based Moderna vaccine


In US, the Massachusetts-based biotech company Moderna is developing an RNA based vaccine in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID). The vaccine candidate mRNA-1273 has already conducted phase 1 trials and is all set to begin phase 2 trials. The RNA vaccine works by entering the human cells and carries the molecular instructions to make the viral protein. Once, this viral protein is recognized by the body, the immune system of the body is triggered.


3. Beijing-based Sinovac Biotech


Chinese scientists are claiming to have successfully tested a potential vaccine for the novel coronavirus in monkeys. To conduct this experiment, the researchers injected the monkeys with the potential vaccine PiCoVacc which is made by Sinovac Biotech, a Chinese biopharmaceutical company. The monkeys were later exposed to novel coronavirus and it was found that those injected with a dose of the potential vaccine were largely protected from the virus. The vaccine is currently undergoing human clinical trials.


4. Pfizer and BioNtech vaccine


US-based Pfizer pharmaceutical company and its German partner BioNtech are working together on four RNA vaccine candidates. They also began clinical trials of their vaccine candidate BNT162. Their vaccine candidate is based on specially designed messenger RNA (similar to the Moderna vaccine) and the trails for testing the vaccine are taking place in the USA and they plan to test the potential vaccine on 360 healthy volunteers



21 views0 comments

Comentarios


Popular Searches

Biomedical Engineering Training | Product Design Training and Workshop | Medical Device service | Medical Device Sales | Medical devices Calibration | Medical Device Testing | Architecture and Healthcare Spaces | Website and Digital Marketing for Healthcare Research and Development Projects | Product Commercialization | Oxygen Concentrator Rentals in Chennai | Sleep Therapy in Chennai | Interior and Exterior Design | Branding | 
Biomedical Training | Biomedical Internships | Biomedical Projects | Chennai | Tamilnadu | India | Oxygen Concentrator Rental | BiPAP Rental | CPAP Service | Research Writing Services | Biomedical Workshops | Healthcare Training​ | Medical Equipment Rental | Biomedical Research​ | Clinical Workshops Medical Device Service​ | Healthcare Internships | Biomedical Education​ | Respiratory Therapy Equipment | Biomedical Engineering Projects 

Medcuore Medical Solutions Pvt.Ltd is a Bio medical Startup in chennai comprising a team of skilled of personnel that deals with sales,service,maintenance ,calibration,and testing of medical devices and equipment.medcuore creative the dessign department of medcuore,provides creative services in Digital Marketing ,Healthcare production and architechtural design

Startup Block II, Crescent Innovation and Incubation Council, B.S. Abdur Rahman Crescent Institute of Science and Technology,
GST Road, Chennai - 600048,

Tamil Nadu, India

Contact: +91 93605 83390
email: support@medcuore.com 

MedCuore StartupIndia
ISO Logo

©MedCuore2020

bottom of page